Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • BFSI
      • Capital Goods
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Lifestyle»Avesthagen’s Teestar® Botanical Chewables Named Finalist For NutraIngredients-Asia 2023 Award Singapore
    Lifestyle

    Avesthagen’s Teestar® Botanical Chewables Named Finalist For NutraIngredients-Asia 2023 Award Singapore

    By August 23, 2023No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Teestar by Avesthagen

    Bangalore (Karnataka) [India], August 23: Teestar® botanical chewables by Avesthagen Limited, a product designed for sugar and weight management, specifically targeting pre-diabetic and diabetic healthcare. Teestar® is a scientifically formulated nutraceutical using all-natural plant-based ingredients. The product has gained recognition as a finalist for the NutraIngredients-Asia 2023 Award and will be showcased at the show at Marina Bay Sands in Singapore on September 26th 2023. 

    With an emphasis on preventive care and general wellness, Avesthagen’s line of bioactive compounds aims to offer naturally occurring, clinically confirmed treatments for numerous disease-specific health issues like Diabetes and Cardiovascular Health. Teestar® chewables are developed to help manage blood sugar levels, particularly after meals, with reported reductions in postprandial blood glucose levels of up to 10 mg/dL. The product also aids in better insulin response.

    Teestar® is formulated from an Indian medicinal plant that has traditionally been a part of the food matrix. The recommended dosage for Teestar® is to consume two chewables before breakfast and dinner daily for optimal results. 

    Dr. Renuka Jain, President of Avesta Nordic Research Pvt. Ltd., explains that Teestar® forms a colloidal-type suspension in the stomach and intestines upon hydration. This leads to slower gastrointestinal transit and digestion of food, resulting in lesser glucose being absorbed from digested food and a prolonged feeling of satiety.

    Teestar® is manufactured in a state-of-the-art production and R&D facility using an eco-friendly and safe extraction process that uses only ethanol and water. Using Avesthagen’s unique fingerprinting method, MetaGrid®, the product’s consistency in quality is maintained.

    Event Showcase: Teestar® Botanical Chewables have been selected as a finalist and are scheduled to be showcased at the Nutra Ingredient Asia Show, which will take place at Marina Bay Sands in Singapore on September 26th, 2023. This event aims to highlight Avesthagen’s ‘Food for Medicine’ program, which is focused on the scientific validation of traditional medicine knowledge and natural plant ingredients leading to plant-based medicines for preventive healthcare and treatment of specific disease conditions.

    Teestar® Botanical Chewables are promoted as a safe and potent calorie modulator that can assist in managing healthy body mass.

    Teestar® is available in two flavors: Litchi and Tamarind, priced at Rs. 750/-. The websites www.avestagoodearthfoods.com, www.amazon.in, and www.1mg.com offer it for sale.

    About Avesthagen: 

    Avesthagen Limited is an international and diversified life sciences company that follows a systems-biology approach. The company is a pioneer in merging the fields of food, pharmaceuticals, and population genetics to create innovative products and therapies. Avesthagen’s focus lies in bringing its developed products and technologies to the market, with a particular emphasis on Nutrigenomics, Agriculture, and Precision Medicine. They utilize their proprietary Predictive, Preventive, and Personalized (“PPP”) healthcare platform to achieve these goals.

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    lifestyle
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Engineers’ Day Celebrated at IPS Academy, Institute of Engineering and Science, Indore

    September 19, 2026

    India International Jewellery Awards 2026 Receives Overwhelming Industry Response with Around 200 Nominations

    September 19, 2026

    ODDS Longevity Concludes ‘The Silent Decade’ Symposium

    September 18, 2026

    Comments are closed.

    Recent Post
    • AM/NS International School’s Geography Teacher Among Top 5 National Finalists in India’s Best Teachers’ Awards 2026
    • NSE Anchor Book Signals a New Balance in India’s Capital Markets
    • Dr. Harshmeet Arora: A Rising Name in Celebrity Nutrition & Psychology
    • Best Crypto Presale: AlphaPepe Nears Stage Sellout with USD 2.7M Raised, Leaving Utility-Free Meme Coins in the Dust
    • Engineers’ Day Celebrated at IPS Academy, Institute of Engineering and Science, Indore
    • IICA Celebrates Its 41st Convocation, Strengthening Industry Partnerships to Shape the Future of Culinary Talent
    • Current Infraprojects Limited Secures Rs 10.42 Cr Order from Bank Note Press, Dewas for 3 MW Rooftop Solar Project
    • India International Jewellery Awards 2026 Receives Overwhelming Industry Response with Around 200 Nominations

    Type above and press Enter to search. Press Esc to cancel.